Additionally, we demonstrated that JARID1B significantly inhibited CDX2 expression in CRC, and CDX2 is crucial for JARID1B-mediated Wnt/β-catenin signalling in CRC. The gene discussed is KDM5B; the disease is colorectal carcinoma.